Dianne Nicol

Summary

Affiliation: University of Tasmania
Country: Australia

Publications

  1. doi Understanding public reactions to commercialization of biobanks and use of biobank resources
    Dianne Nicol
    Centre for Law and Genetics, Faculty of Law, University of Tasmania, Private Bag 89, Hobart, TAS, 7001, Australia Electronic address
    Soc Sci Med 162:79-87. 2016
  2. pmc Using TRIPS flexibilities to facilitate access to medicines
    Dianne Nicol
    University of Tasmania, Faculty of Law, Private Bag 89, Hobart, Tasmania 7001, Australia
    Bull World Health Organ 91:533-9. 2013
  3. doi Do patents impede the provision of genetic tests in Australia?
    Dianne Nicol
    Law Faculty, University of Tasmania, Hobart, Australia
    Aust Health Rev 37:281-5. 2013
  4. ncbi Balancing innovation and access to healthcare through the patent system--an Australian perspective
    Dianne Nicol
    Centre for Law and Genetics, Law Faculty, University of Tasmania, Hobart, TAS, Australia
    Community Genet 8:228-34. 2005
  5. pmc Community engagement for big epidemiology: deliberative democracy as a tool
    Rebekah E McWhirter
    Menzies Institute for Medical Research, University of Tasmania, Hobart TAS 7000, Australia
    J Pers Med 4:459-74. 2014
  6. ncbi Personalised medicine in the genome era
    Don Chalmers
    Centre for Law and Genetics, University of Tasmania, Private Bag 89, Hobart, TAS 7001, Australia
    J Law Med 20:577-94. 2013
  7. ncbi Balancing access to pharmaceuticals with patent rights
    Dianne Nicol
    Law School, University of Tasmania, Australia
    Monash Bioeth Rev 22:50-62. 2003
  8. doi Genomics in research and health care with Aboriginal and Torres Strait Islander peoples
    Rebekah McWhirter
    Menzies Institute for Medical Research, University of Tasmania, Private Bag 23, Hobart, TAS, 7000, Australia
    Monash Bioeth Rev 33:203-9. 2015
  9. doi Are the gene-patent storm clouds dissipating? A global snapshot
    Johnathon Liddicoat
    Centre for Law and Genetics, Faculty of Law, University of Tasmania, Hobart, Tasmania, Australia
    Nat Biotechnol 33:347-52. 2015
  10. pmc Has the biobank bubble burst? Withstanding the challenges for sustainable biobanking in the digital era
    Don Chalmers
    Centre for Law and Genetics, Faculty of Law, University of Tasmania, Hobart, Tasmania, Australia
    BMC Med Ethics 17:39. 2016

Detail Information

Publications15

  1. doi Understanding public reactions to commercialization of biobanks and use of biobank resources
    Dianne Nicol
    Centre for Law and Genetics, Faculty of Law, University of Tasmania, Private Bag 89, Hobart, TAS, 7001, Australia Electronic address
    Soc Sci Med 162:79-87. 2016
    ....
  2. pmc Using TRIPS flexibilities to facilitate access to medicines
    Dianne Nicol
    University of Tasmania, Faculty of Law, Private Bag 89, Hobart, Tasmania 7001, Australia
    Bull World Health Organ 91:533-9. 2013
    ..Draft legislation currently being considered in Australia is used to illustrate how workable legislative frameworks can be developed. ..
  3. doi Do patents impede the provision of genetic tests in Australia?
    Dianne Nicol
    Law Faculty, University of Tasmania, Hobart, Australia
    Aust Health Rev 37:281-5. 2013
    ....
  4. ncbi Balancing innovation and access to healthcare through the patent system--an Australian perspective
    Dianne Nicol
    Centre for Law and Genetics, Law Faculty, University of Tasmania, Hobart, TAS, Australia
    Community Genet 8:228-34. 2005
    ....
  5. pmc Community engagement for big epidemiology: deliberative democracy as a tool
    Rebekah E McWhirter
    Menzies Institute for Medical Research, University of Tasmania, Hobart TAS 7000, Australia
    J Pers Med 4:459-74. 2014
    ..Deliberative democracy methodology is a useful tool for community engagement that addresses some of the limitations of traditional consultation methods. ..
  6. ncbi Personalised medicine in the genome era
    Don Chalmers
    Centre for Law and Genetics, University of Tasmania, Private Bag 89, Hobart, TAS 7001, Australia
    J Law Med 20:577-94. 2013
    ..The authors identify a number of ethical concerns that need to be addressed if the promise of personalised medicine is to be fully realised...
  7. ncbi Balancing access to pharmaceuticals with patent rights
    Dianne Nicol
    Law School, University of Tasmania, Australia
    Monash Bioeth Rev 22:50-62. 2003
    ..This article discusses the extensive international negotiations occurring during the last couple of years that seek to provide an appropriate balance between access rights and patent rights...
  8. doi Genomics in research and health care with Aboriginal and Torres Strait Islander peoples
    Rebekah McWhirter
    Menzies Institute for Medical Research, University of Tasmania, Private Bag 23, Hobart, TAS, 7000, Australia
    Monash Bioeth Rev 33:203-9. 2015
    ....
  9. doi Are the gene-patent storm clouds dissipating? A global snapshot
    Johnathon Liddicoat
    Centre for Law and Genetics, Faculty of Law, University of Tasmania, Hobart, Tasmania, Australia
    Nat Biotechnol 33:347-52. 2015
    ..In genetic diagnostics testing, what are the boundaries of the global patent problem, and is there a real risk that patents and licensing practices could impede access to tests?..
  10. pmc Has the biobank bubble burst? Withstanding the challenges for sustainable biobanking in the digital era
    Don Chalmers
    Centre for Law and Genetics, Faculty of Law, University of Tasmania, Hobart, Tasmania, Australia
    BMC Med Ethics 17:39. 2016
    ..This article aims to provide a review of the issues associated with biobank practices and governance, with a view to informing the future course of both large-scale and smaller scale biobanks. ..
  11. ncbi Benefit sharing and biobanking in Australia
    Dianne Nicol
    University of Tasmania, Australia
    Public Underst Sci 21:534-55. 2012
    ..The third is not clearly linked with any one norm of sharing behaviour. The implications of these findings on biobank benefit sharing arrangements are discussed. ..
  12. ncbi Human genetic research databases and biobanks: towards uniform terminology and Australian best practice
    Don Chalmers
    University of Tasmania, Australia
    J Law Med 15:538-55. 2008
    ..This article reviews these international best practices with the aim of providing guidance for the development of appropriate regulatory structures in Australia...
  13. ncbi Gene patents--more evidence needed, but policymakers must act
    E Richard Gold
    Nat Biotechnol 25:388-9. 2007
  14. ncbi Trust, patents and public perceptions: the governance of controversial biotechnology research
    Timothy Caulfield
    Health Law Institute, University of Alberta, Canada
    Nat Biotechnol 24:1352-4. 2006
    ..The sustainability of many research endeavors, particularly in controversial areas, requires an understanding of public concerns. As such, governance strategies should be developed to sustain public trust...
  15. ncbi Human gene patents: under whose control?
    Dianne Nicol
    Med J Aust 179:181-2. 2003